These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7777386)

  • 21. A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease.
    Pocchiari M; Salvatore M; Cutruzzolá F; Genuardi M; Allocatelli CT; Masullo C; Macchi G; Alemá G; Galgani S; Xi YG
    Ann Neurol; 1993 Dec; 34(6):802-7. PubMed ID: 7902693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease.
    Jarius C; Kovacs GG; Belay G; Hainfellner JA; Mitrova E; Budka H
    Acta Neuropathol; 2003 May; 105(5):449-54. PubMed ID: 12677444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathological characteristics of Creutzfeldt-Jakob disease with a PrP V180I mutation and M129V polymorphism on different alleles].
    Iwaski Y; Sone M; Kato T; Yoshida E; Indo T; Yoshida M; Hashizume Y; Yamada M
    Rinsho Shinkeigaku; 1999 Aug; 39(8):800-6. PubMed ID: 10586622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease.
    Wong BS; Green AJ; Li R; Xie Z; Pan T; Liu T; Chen SG; Gambetti P; Sy MS
    J Pathol; 2001 May; 194(1):9-14. PubMed ID: 11329135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creutzfeldt-Jakob disease: a protein disease.
    Knight R
    Proteomics; 2001 Jun; 1(6):763-6. PubMed ID: 11677782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism at 3' UTR +28 of the prion-like protein gene is associated with sporadic Creutzfeldt-Jakob disease.
    Jeong BH; Kim NH; Choi EK; Lee C; Song YH; Kim JI; Carp RI; Kim YS
    Eur J Hum Genet; 2005 Sep; 13(9):1094-7. PubMed ID: 15986038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
    Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
    Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease.
    Schulz-Schaeffer WJ; Giese A; Windl O; Kretzschmar HA
    Clin Neuropathol; 1996; 15(6):353-7. PubMed ID: 8937783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.
    Collinge J; Sidle KC; Meads J; Ironside J; Hill AF
    Nature; 1996 Oct; 383(6602):685-90. PubMed ID: 8878476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
    Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P
    Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment.
    Roeber S; Krebs B; Neumann M; Windl O; Zerr I; Grasbon-Frodl EM; Kretzschmar HA
    Acta Neuropathol; 2005 Apr; 109(4):443-8. PubMed ID: 15739100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New variant Creutzfeldt-Jakob disease.
    Gordon N
    Int J Clin Pract; 1999 Sep; 53(6):456-9. PubMed ID: 10622074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Juvenile form of Creutzfeldt-Jakob disease. Clinical and neuropathological aspects].
    Billette de Villemeur T
    Pathol Biol (Paris); 1995 Feb; 43(2):91-6. PubMed ID: 7777385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Creutzfeldt-Jakob disease secondary to treatment with growth hormone].
    Beauvais P; Billette de Villemeur T
    Presse Med; 1993 Jun; 22(23):1077-8. PubMed ID: 8415458
    [No Abstract]   [Full Text] [Related]  

  • 36. CJD discrepancy.
    Doh-ura K; Kitamoto T; Sakaki Y; Tateishi J
    Nature; 1991 Oct; 353(6347):801-2. PubMed ID: 1682813
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
    Gibbs CJ; Joy A; Heffner R; Franko M; Miyazaki M; Asher DM; Parisi JE; Brown PW; Gajdusek DC
    N Engl J Med; 1985 Sep; 313(12):734-8. PubMed ID: 2863752
    [No Abstract]   [Full Text] [Related]  

  • 38. Valine homozygous 129 PrP genotype in a French growth-hormone-related Creutzfeldt-Jakob disease patient.
    Labauge P; Pagès M; Blard JM; Chatelain J; Laplanche JL
    Neurology; 1993 Feb; 43(2):447. PubMed ID: 8437720
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
    Collinge J; Palmer MS; Dryden AJ
    Lancet; 1991 Jun; 337(8755):1441-2. PubMed ID: 1675319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prions, Jakob-Creutzfeldt disease and human growth hormone].
    González PM
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):207-9. PubMed ID: 3296112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.